Cyclarity Therapeutics, Inc. — Form D
Cyclarity Therapeutics, Inc. of Novato, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-07. The offering totals $10.0M, of which $3.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-09-07
- Form: D
- Accession: 0001794705-21-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $3.5M
- Remaining: $6.5M
- Investors: 10
- Date of first sale: 2021-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-412530
Issuer
- Name: Cyclarity Therapeutics, Inc.
- CIK: 0001794705
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 8001 Redwood Blvd, Novato, CA, 94945
- Phone: 6509065631
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Frank Schueler | Director | Mountain View, CA |
| Matthew O'Connor | Director | Austin, TX |
| Matthew O'Connor | Executive Officer | Austin, TX |
| Michael Kope | Director | Novato, CA |
| Michael Kope | Executive Officer | Novato, CA |
Other filings by this issuer (2)
More